Cite
HARVARD Citation
Yossef, S. et al. (2020). An Oral Formulation of the Probiotic, Bacillus subtilis HU58, Was Safe and Well Tolerated in a Pilot Study of Patients with Hepatic Encephalopathy. Evidence-based complementary and alternative medicine. p. . [Online].